The Actelion code of conduct is the foundation of our corporate culture and defines the core principles and ethical standards by which we create value in our company. It is the responsibility of every Actelion employee to be familiar with, and to comply with, our code of conduct.

We continue to be proactive in establishing policies and practices that support strong corporate governance and transparency. These policies and practices are continually reviewed and enhanced as appropriate.

In 2013, Actelion created an Ethics and Compliance committee. The committee is comprised of the following: Group Compliance Officer, Chief Financial Officer, Head of Global Quality Management, Head of Global Human Resources, Head of Global Clinical Development, Chief Operating Officer, the Group General Counsel and a Drug Discovery Representative.

The main tasks of the committee are the following:

  • Promote a culture that encourages professional conduct, respect for and compliance with Actelion's policies and procedures, and adherence to the laws and regulations that govern the business of the company.
  • Review and assess compliance matters identified by various functions within Actelion that have compliance-related responsibilities which may have a significant impact upon the business operations, financial performance or public image of the company.
  • Bring enterprise-level compliance risks to the attention of Actelion's senior management and Board of Directors, as appropriate, on a consolidated basis. 
  • Monitor and report upon mitigation activities undertaken within Actelion to remediate identified compliance and ethics issues.
  • Review, monitor and make recommendations to senior management and the Board of Directors on corporate policies and practices with regard to applicable legal and regulatory requirements, industry standards, and the Actelion Code of Conduct.

Actelion understands the importance of protecting personal information and applying the highest ethical and regulatory standards. We are committed to respecting our stakeholders’ privacy and safeguarding all their personal information. Actelion’s data protection policy covers data on patients, healthcare professionals, customers, suppliers and employees.

To ensure the integrity and privacy of the personal and health-related information provided to us, we use state-of-the-art information security programs, focusing on protection of sensitive information and detection of unauthorized access. In 2016, Actelion received no substantiated complaints regarding breaches of customer privacy or losses of customer data.

Full compliance with applicable laws in all the regions where Actelion operates is crucial to our success.

Actelion’s position is clearly stated in our Anti-Corruption and Anti-Bribery Policy: We take a zero‑tolerance approach to bribery and corruption and are committed to acting professionally in all our business dealings and relationships wherever we operate. We implement and enforce effective systems to counter bribery. We will uphold all laws relevant to countering bribery and corruption in all the jurisdictions in which we operate. All Actelion employees are required to complete training on this policy.

In 2015, all of Actelion’s operations were reviewed for the first time using an online compliance assessment tool, which also covers risks related to corruption and bribery. The results of this assessment were used to refine the questionnaire, and it now forms part of an annual review which will provide an overview of the implementation of compliance programs. Each affiliate is evaluated with the aid of the Transparency International Corruption Perceptions Index and, based on the outcome, steps are taken to mitigate any risks.

We have a fundamental responsibility to market our medicines in a way that enhances patient care by helping healthcare professionals to make informed prescribing decisions. Ensuring high ethical standards in all our sales and marketing activities is a top priority, and all colleagues who interact with healthcare professionals receive specific training as part of our overall commitment to responsible business practices.

In 2015, we updated our policy on interactions with healthcare professionals. Reflecting changes in today’s healthcare environment, the updated policy incorporates the provisions of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice, the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code, and other applicable industry codes.

In 2016, fewer than 10 incidents were reported relating to professional practices (i.e. compliance with internal marketing codes and with industry codes and regulations). In substantiated cases, appropriate disciplinary action was taken.

Actelion respects the rights of its employees as set out in the Universal Declaration of Human Rights, and we fully comply with all relevant laws, rules and regulations governing labor, employment and the employment relationship in all the countries where we operate.

We respect the right of all employees to join a legally recognized employee association, and we comply with all laws relating to employee representation. We strive to maintain an open dialogue with all our employees and their representatives.

Due to the nature of our business and the location of our operations, the risk of child or forced labor is minimal. We do, however, remain vigilant for unexpected issues that may arise – not only in our own operations but also in relation to our procurement practices. Our expectations regarding working conditions, human rights protection, business ethics, legal compliance and environmental protection are set out in our Supplier Code of Conduct.

Administrative Assistant, Clinical Development 


"The level of commitment and excitement about what we do is contagious. It makes you want to come to work each day."